📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
27
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
23%
💰 Capital Raise
38%
• Active shelf registration ($33M, 1% of market cap)
• Active ATM program with $76M remaining capacity
📜 Warrant Exercise
15%
• Warrant overhang: 10.7% of shares outstanding
💹 Market Data
Market Cap$6.25B
Shares Outstanding223.04M
Float176.33M
Cash$1.75B
Debt$1.28M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 43.58M shares
#1
Bayshore Capital Advisors, LLC
8.74M shares
#2
Alyeska Investment Group, L.p.
7.80M shares
#3
Blackrock Inc.
6.39M shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest23.96M
Days to Cover1.3
% of Float13.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Sep 30, 2024
S-3
SHELF
May 13, 2026
4
INSIDER TRANSACTION
Apr 22, 2026
4
INSIDER TRANSACTION
Apr 21, 2026
Full SEC filing analysis available with free account →
📰 Recent News
🔬 More Research for USAR
📊 USAR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 USAR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.